The Effects of Flecainide Acetate on Inflammatory-Immune Response in Lipopolysaccharide-Stimulated Neutrophils and on Mortality in Septic Rats
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Flecainide acetate is a drug used primarily for cardiac arrhythmia. Some studies also imply that flecainide acetate has the potential to regulate inflammatory-immune responses; however, its mechanism of action is contended. We determined the effects of flecainide acetate on lipopolysaccharide (LPS)-stimulated human neutrophils in vitro and on mortality in a septic rat model. Methods: Neutrophils from human blood were cultured with varying concentrations of flecainide acetate (1 μM, 10 μM, or 100 μM) with or without LPS (100 ng/ml). To assess neutrophil activation, the protein levels of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 and IL-8 were measured after a 4-hour culture period. To assess the intracellular signaling pathways, the levels of phosphorylation of p38 mitogen-activated protein kinase (p38), extracellular signal-regulated kinase (ERK) 1/2, and c-Jun N-terminal kinase (JNK) were measured after a 30-minute culture period, and the nuclear translocation of nuclear factor (NF)-κB was measured after a 1-hour culture period. Additionally, the survival rate was investigated in a rat sepsis model. Results: Flecainide acetate down-regulated the activation of proinflammatory cytokines, including TNF-α and IL-6 and IL-8, and intracellular signaling pathways including ERK 1/2 and NF-κB. Flecainide acetate also improved the survival rate in the rat sepsis model. Conclusions: Collectively, these findings indicate that flecainide acetate can improve survival in a rat sepsis model by attenuating LPS-induced neutrophil responses. We therefore suggest that flecainide acetate plays an important role in modulating inflammatoryimmune responses.
Abstract
Background: Flecainide acetate is a drug used primarily for cardiac arrhythmia. Some studies also imply that flecainide acetate has the potential to regulate inflammatory-immune responses; however, its mechanism of action is contended. We determined the effects of flecainide acetate on lipopolysaccharide (LPS)-stimulated human neutrophils in vitro and on mortality in a septic rat model. Methods: Neutrophils from human blood were cultured with varying concentrations of flecainide acetate (1 μM, 10 μM, or 100 μM) with or without LPS (100 ng/ml). To assess neutrophil activation, the protein levels of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 and IL-8 were measured after a 4-hour culture period. To assess the intracellular signaling pathways, the levels of phosphorylation of p38 mitogen-activated protein kinase (p38), extracellular signal-regulated kinase (ERK) 1/2, and c-Jun N-terminal kinase (JNK) were measured after a 30-minute culture period, and the nuclear translocation of nuclear factor (NF)-κB was measured after a 1-hour culture period. Additionally, the survival rate was investigated in a rat sepsis model. Results: Flecainide acetate down-regulated the activation of proinflammatory cytokines, including TNF-α and IL-6 and IL-8, and intracellular signaling pathways including ERK 1/2 and NF-κB. Flecainide acetate also improved the survival rate in the rat sepsis model. Conclusions: Collectively, these findings indicate that flecainide acetate can improve survival in a rat sepsis model by attenuating LPS-induced neutrophil responses. We therefore suggest that flecainide acetate plays an important role in modulating inflammatoryimmune responses.
참고문헌 (26)
- Ferrer R, "Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guidelinebased performance improvement program", Crit Care Med, 42, pp.1749~1755 (2014)[DOI]
- Rhee C, "Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009- 2014", JAMA, 318, pp.1241~1249 (2017)[DOI]
- van Zanten AR, "Guideline bundles adherence and mortality in severe sepsis and septic shock", Crit Care Med, 42, pp.1890~1898 (2014)[DOI]
- Singer M, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)", JAMA, 315, pp.801~810 (2016)[DOI]
- Doerschuk CM, "CD11", CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take?, 2000, pp.23, 133~136
- Windsor AC, "Role of the neutrophil in adult respiratory distress syndrome", Br J Surg, 80, pp.10~17 (1993)[DOI]
- Samlowski WE, "Flecanideinduced immune neutropenia: documentation of a hapten-mediated mechanism of cell destruction", Arch Intern Med, 147, pp.383~384 (1987)[DOI]
- Nojima S, "Selective inhibition of human TNF-alpha action by flecainide acetate, an antiarrhythmic drug", Physiol Chem Phys Med NMR, 27, pp.77~89 (1995)
- Kwak SH, "The kringle domain of urokinasetype plasminogen activator potentiates LPS-induced neutrophil activation through interaction with <TEX>${\alpha}V{\beta}3$<", TEX> integrins, 2005, pp.78, 937~945
- Yum HK, "Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury", J Immunol, 167, pp.6601~6608 (2001)[DOI]
- Arcaroli J, "Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia", J Leukoc Biol, 72, pp.571~579 (2002)
- Harris VK, "Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus", J Indian Med Assoc, 98, pp.391~393 (2000)
- Nick JA, "Selective activation and functional significance of <TEX>$p38{\alpha}$<", TEX> mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils, 1999, pp.103, 851~858
- Baigrie RJ, "Systemic cytokine response after major surgery", Br J Surg, 79, pp.757~760 (1992)[DOI]
- Selvatici R, "Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils", Eur J Pharmacol, 534, pp.1~11 (2006)[DOI]
- Avdi NJ, "Tumor necrosis factoralpha activation of the c-Jun N-terminal kinase pathway in human neutrophils: integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis", J Biol Chem, 276, pp.2189~2199 (2001)[DOI]
- Rane MJ, "Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase", J Immunol, 159, pp.5070~5078 (1997)
- Goebel LJ, "Correlates of youth smokeless tobacco use", Nicotine Tob Res, 2, pp.319~325 (2000)[DOI]
- Esmon CT, "Inflammation, sepsis, and coagulation", Haematologica, 84, pp.254~259 (1999)
- Hardaway RM, "A review of septic shock", Am Surg, 66, pp.22~29 (2000)
- Karima R, "The molecular pathogenesis of endotoxic shock and organ failure", Mol Med Today, 5, pp.123~132 (1999)[DOI]
- Lien E, "Toll-like receptors", Crit Care Med, 30(1 Supp), pp.S1~S11 (2002)[DOI]
- Pace JL, "Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide", J Immunol, 126, pp.1863~1867 (1981)
- West MA, "Whole blood leukocyte mitogen activated protein kinases activation differentiates intensive care unit patients with systemic inflammatory response syndrome and sepsis", J Trauma, 62, pp.805~811 (2007)[DOI]
- Khan I, "Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1ss and ERK mitogen-activated protein kinase", Scand J Gastroenterol, 40, pp.578~585 (2005)
- Sikes PJ, "Sodium", hydrogen exchange activity in sepsis and in sepsis complicated by previous injury: 31P and 23Na NMR study, 2005, pp.33, 605~615